We are live on ! Find out more
AMAM

Ambrx Biopharma Inc

Delisted

AMAM was delisted on the 6th of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$34.8M -$13.4K -1,200 -0%
BlackRock
2
BlackRock
New York
$25.9M +$22.9M +2,049,265 +250%
CAM
3
Cormorant Asset Management
Massachusetts
$22.5M
AG
4
Artal Group
Luxembourg
$19.4M +$14.5M +1,302,291 +153%
FI
5
Fosun International
China
$17.5M
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$17.4M +$1.08M +96,408 +5%
SCM
7
Suvretta Capital Management
New York
$9.55M +$11.8M +1,057,735 New
OCA
8
Octagon Capital Advisors
New York
$3.04M -$147K -13,132 -4%
Millennium Management
9
Millennium Management
New York
$889K -$480K -43,012 -30%
Norges Bank
10
Norges Bank
Norway
$632K
Tudor Investment Corp
11
Tudor Investment Corp
Connecticut
$182K
CCM
12
CAAS Capital Management
New York
$118K -$301K -26,932 -67%
Renaissance Technologies
13
Renaissance Technologies
New York
$107K +$132K +11,800 New
Morgan Stanley
14
Morgan Stanley
New York
$25K
MIFH
15
Migdal Insurance & Financial Holdings
Israel
$1K -$848 -76 -38%
Bank of America
16
Bank of America
North Carolina
$1K +$335 +30 +30%
GCM
17
Ghisallo Capital Management
Massachusetts
-$203K -15,000 Closed